Veracyte, Inc. (VCYT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 21.41 |
| Open | 21.22 |
| Bid | 21.71 x 400 |
| Ask | 21.79 x 200 |
| Day's range | 20.86 - 21.98 |
| 52-week range | 18.61 - 30.52 |
| Volume | |
| Avg. volume | 673,066 |
| Market cap | 1.664B |
| Beta (5Y monthly) | 1.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Veracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid Tumors
SOUTH SAN FRANCISCO, Calif., June 03, 2024--Veracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid Tumors.
- Business Wire
Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer
SOUTH SAN FRANCISCO, Calif., May 22, 2024--Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer.
- Business Wire
Veracyte to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., May 15, 2024--Veracyte, Inc. (Nasdaq: VCYT) a leading cancer diagnostics company, today announced it will participate in the following investor conferences.
© 2024 Yahoo. All rights reserved.